Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

UroGen Pharma (URGN) Shares Outstanding: 2016-2025

Historic Shares Outstanding for UroGen Pharma (URGN) over the last 8 years, with Sep 2025 value amounting to $46.8 million.

  • UroGen Pharma's Shares Outstanding rose 10.88% to $46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year increase of 10.88%. This contributed to the annual value of $42.2 million for FY2024, which is 29.98% up from last year.
  • UroGen Pharma's Shares Outstanding amounted to $46.8 million in Q3 2025, which was up 1.26% from $46.2 million recorded in Q2 2025.
  • Over the past 5 years, UroGen Pharma's Shares Outstanding peaked at $46.8 million during Q3 2025, and registered a low of $22.3 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding was $41.2 million (2024), whereas its average is $37.4 million.
  • Data for UroGen Pharma's Shares Outstanding shows a peak YoY soared of 75.20% (in 2024) over the last 5 years.
  • UroGen Pharma's Shares Outstanding (Quarterly) stood at $22.5 million in 2021, then increased by 2.97% to $23.1 million in 2022, then spiked by 40.47% to $32.5 million in 2023, then climbed by 29.98% to $42.2 million in 2024, then climbed by 10.88% to $46.8 million in 2025.
  • Its Shares Outstanding stands at $46.8 million for Q3 2025, versus $46.2 million for Q2 2025 and $46.1 million for Q1 2025.